OMRON M7 Intelli IT

OMRON M7 Intelli IT

Get the same consistent accuracy as in your doctor’s office!

OMRON M7 Intelli IT

OMRON M7 Intelli IT, our most advanced device, brings to market our latest innovation in accuracy: Intelli Wrap Cuff while embedding our first OMRON smartphone app: OMRON connect

OMRON M7 INTELLI IT FEATURES

• Average 3 Readings

  Average of 3 consecutive readings in 10 minutes

 

• Movement Sensor

  Body Movement Detection

 

• Clinically Validated

  The device has proven its reliability and accuracy under vigorous testing procedures by major health organisations

 

• Cuff Wrap Guide

  Indicates if cuff is wrapped correctly: not too loose or too tight

 

• Easy Blood Presure Colour Indicator

  LED indicator: normal (green) or high (red)

 

• Irregular Heartbeat Detection

  Indicates if Irregular Heartbeat is detected

 

• Memory

  Keep track of your data

 

• Morning Hypertension

  Allows you to track whether your morning measurement is different from the rest of the day

• 1 out of 3 people measure incorrectly³

  This comes from the fact that the standard cuff has to be positioned in a very specific area above the artery, on the upper arm.

  SOLUTION

  OMRON Intelli Wrap Cuff technology assures consistent accuracy from any position around the upper arm.

  Intelli Wrap Cuff consistent accuracy is:

  • confirmed by golden standard

  • even for arms with size 22-42 cm

    Integrate with the world!

    Smartphone application that connects to OMRON Bluetooth Smart devices and provides easy display of device measurements, history graphs and averages. 

    Makes it easy to view, save, and share your health data by e-mail or with other apps, like Apple Health.

  • Cardiovascular diseases

    Heart diseases such as a cardiac infarction or angina as well as cerebrovascular events such as a cerebral stroke or cerebral hemorrhage are considered to be the main cause of death in the Europe, Africa and the Eastern Mediterranean (EMEA) region. It is projected that they account for 6.5 million deaths each year (WHO Global Health Info, Statistics Reports, 2013) within the EMEA region. Even when these events do not result in death, cerebral and cardiovascular patients will often experience a decrease in quality of life because they have become bedridden or suffer from speech deficits. It is therefore that cerebral and cardiovascular diseases are considered to be one of the major causes of the gap between a healthy lifespan and an average life expectancy.